Scale, Bail, or Fail – The B-Cell Lymphoma Edition

Jointly provided by

Support for this activity has been provided through educational grants from AbbVie Inc.; AstraZeneca Pharmaceuticals LP; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Release date: 8/10/2020

Expiration date:  8/10/2021

Estimated time to complete: 0.5 hours

Overview

Over the last several decades, advances in non-Hodgkin B-cell lymphoma management—including non–chemotherapy-based targeted therapies and new cytogenetic and molecular prognostic testing—have significantly improved patient survival. For clinicians who provide care to patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), keeping pace with these advances and incorporating them into practice can present a challenge.

In the format of an entertaining (but challenging!) interactive game, this edition of Scale, Bail, or Fail presents and discusses the recent drug approvals, emerging therapies, and new guideline recommendations that are changing the treatment landscape and further improving survival for CLL and MCL patients. This activity also features downloadable resources. 

Faculty

Colleen Harker Erb, MSN, CRNP, ACNP-BC, AOCNP
Outpatient Nurse Practitioner
Abramson Cancer Center – Penn Medicine
Philadelphia, Pennsylvania

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
Nurse Practitioner
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Target Audience

This activity has been designed to meet the educational needs of oncology nurse practitioners (NPs), physician assistants (PAs), nurse specialists, and other health care providers involved in the management of oncology patients. 

Learning Objectives

Upon completion of this activity, participants should be better able to:

• Interpret cytogenetic, molecular, and other standard staging tests to define risk and prognosis
• Distinguish the indicated uses, mechanisms of action, depth and duration of clinical response, and safety of current and emerging targeted agents
• Evaluate recent data on treatment advances and strategies for managing CLL and MCL and their potential implications for clinical practice
• Outline a treatment plan to achieve the deepest and most durable response while balancing the adverse effects and risk for toxicities in fit and unfit patients

Accreditation and Credit Designation

CME 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Horizon CME and RedMedEd. Horizon CME is accredited by the ACCME to provide continuing medical education for physicians. Horizon CME designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM.

ANCC  

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center (ANCC)’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation (NPHF), RedMedEd, and Horizon CME. NPHF is accredited as a provider of nursing continuing professional development by the ANCC’s Commission on Accreditation. Upon completion, NPs and RNs will earn 0.5 credits and 0.5 pharmacology hours.

Disclosure

In accordance with the ACCME Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of everyone in a position to control content of an educational activity. A relevant financial relationship is a relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CE activity content over which the individual has control. Relationship information appears below:

Colleen Erb, MSN, CRNP, ACNP-BC, AOCNP (faculty) and Christopher D’Andrea, MA, MSPAS, PA-C (peer reviewer) disclose no relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients during the past 12 months. 

Other Contributor/Planner Disclosures

Additional nonfaculty contributors and others involved in the planning, development, and editing or review of the content disclose no relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by or used on patients during the past 12 months.

Unapproved Product Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. RedMedEd; Horizon CME; NPHF; AbbVie Inc.; AstraZeneca Pharmaceuticals LP; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. do not recommend the use of any agent outside the labeled indications.

Disclaimer

The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of RedMedEd; Horizon CME; NPHF; AbbVie Inc.; AstraZeneca Pharmaceuticals LP; and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CME credit, participants must complete a full round of the game (achieving the required score) and the program activity evaluation. Certificates can be printed immediately. 

Contact Information

For questions regarding CME credit, contact Horizon CME, at (503) 659-5558 or info@horizoncme.com. 
For technical questions related to this activity, please contact RedMedEd at 610.251.6841 or education@redmeded.com. 

Hardware/Software Requirements

• iPad or iPhones (iOS 11 or higher) and Android (4.0.3 or higher) with an Internet connection
• A computer with an Internet connection
  • Internet browser (PC): Google Chrome, Internet Explorer 9 or higher, or Firefox 26 or higher
  •  Internet browser (Mac): Google Chrome, Firefox 26 or higher, or Safari 5 or higher
  •  Additional software: Adobe Flash Player and/or an HTML 5-capable browser is required for video or audio playback; Adobe Acrobat Reader may occasionally be required

Privacy

This website is managed by RedMedEd, and RedMedEd’s printed privacy policy applies to this site. CME credit for this activity is provided by Horizon CME; ANCC credit is provided by NPHF. If you register for CME or ANCC credit for this educational activity, RedMedEd will forward relevant personally identifiable information to Horizon CME or NPHF so that records can be maintained concerning any credits issued to you. Aggregated data concerning registrations and evaluations may be shared, but RedMedEd will not knowingly share any personally identifiable information. Horizon CME, NPHF, and RedMedEd may use the information you provide on this site to contact you about your credit or other relevant educational activities. For more information, contact info@horizoncme.com

Copyright

© 2020. This CME-certified program is held as copyrighted by RedMedEd, Horizon CME, and NPHF. Through this notice, RedMedEd, Horizon CME, and NPHF grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owners.